Metraipolis › archive › dc_15a2005299c0
Extracellularly Activatable Conjugates of RGD Peptidomimetics and Cryptophycin for αVβ3-Targeted Cancer Therapy — Europe PMC PMID:42315997
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42315997
- DOI
- 10.1002/chem.71270
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:15:38.719Z
- SHA-256 of the archived text
e8a5c02914687c8f38479342740ea205cfb7c78fa3b8af2cbe3bb6ee552bc133- Stable URL of this page
https://metraipolis.com/documento/dc_15a2005299c0
How to cite
Extracellularly Activatable Conjugates of RGD Peptidomimetics and Cryptophycin for αVβ3-Targeted Cancer Therapy — Europe PMC PMID:42315997 — Europe PMC (en), https://europepmc.org/article/MED/42315997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_15a2005299c0 (Metraipolis archive dc_15a2005299c0, sha256 e8a5c02914687c8f38479342740ea205cfb7c78fa3b8af2cbe3bb6ee552bc133)
BibTeX
@misc{dc15a2005299c0,
title = {Extracellularly Activatable Conjugates of RGD Peptidomimetics and Cryptophycin for αVβ3-Targeted Cancer Therapy — Europe PMC PMID:42315997},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42315997},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_15a2005299c0; sha256 e8a5c02914687c8f38479342740ea205cfb7c78fa3b8af2cbe3bb6ee552bc133},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42315997. Agents can read the archived copy with the MCP tool read_document.